In an unprecedented scientific event, I.D. Stem Cells and Genome Institute is pleased to invite you to attend its global press conference, which will be held in Kyiv – Ukraine , August 25, 2025 – 11:00 AM
Research Center
In a significant breakthrough, researchers from Mie University in Japan have been able to remove the extra 21 markers—the primary cause of Down syndrome—from human cells using CRISPR-Cas9 editing technology, a first step that could open new therapeutic avenues for this advanced condition.
- A Pioneering Scientific Partnership Between the University of Sharjah, I.D. Institute for Stem Cells and Genes, and the Funding Company Alfa Group
- Institute's Participation Represented by Dr. Islam Dababseh in the Monthly Meeting of the American Society of Regenerative Medicine (ASRM)
- Dr. Amina Dababsah to Participate in "Being a Healthy Woman - It's Natural" Conference
- Certificate of Appreciation for Dr. Islam Al-Dababseh for His Distinguished Contributions to Stem Cell Treatment of Infertility
- Prominent Participation of the I.D. Stem Cells and Genome Institute at the 5th Global Regenerative Congress in Budva
- Dr. Islam Al-Dababsah participates in the ISSCR 2024 conference in Hamburg
